Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) released its earnings results on Wednesday. The company reported $0.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.08 by $0.04. Zeltiq Aesthetics had a negative return on equity of 9.90% and a net margin of 9.54%. The firm had revenue of $95.20 million for the quarter, compared to analysts’ expectations of $90.84 million. During the same quarter in the previous year, the business posted $0.05 earnings per share. The business’s revenue for the quarter was up 55.6% on a year-over-year basis.

Zeltiq Aesthetics (NASDAQ:ZLTQ) opened at 39.58 on Friday. Zeltiq Aesthetics has a 1-year low of $18.41 and a 1-year high of $41.48. The firm has a market capitalization of $1.57 billion, a price-to-earnings ratio of 59.52 and a beta of 0.89. The company has a 50 day moving average price of $37.69 and a 200-day moving average price of $33.33.

Earnings History for Zeltiq Aesthetics (NASDAQ:ZLTQ)

In related news, insider Keith J. Sullivan sold 8,000 shares of the stock in a transaction dated Friday, November 4th. The stock was sold at an average price of $33.01, for a total transaction of $264,080.00. Following the sale, the insider now owns 82,023 shares of the company’s stock, valued at approximately $2,707,579.23. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Bradley Hauser sold 3,000 shares of the stock in a transaction dated Monday, September 12th. The stock was sold at an average price of $37.33, for a total value of $111,990.00. Following the sale, the vice president now directly owns 46,240 shares in the company, valued at approximately $1,726,139.20. The disclosure for this sale can be found here. Corporate insiders own 15.60% of the company’s stock.

A number of hedge funds have recently modified their holdings of ZLTQ. Louisiana State Employees Retirement System boosted its stake in Zeltiq Aesthetics by 0.7% in the second quarter. Louisiana State Employees Retirement System now owns 14,300 shares of the company’s stock valued at $391,000 after buying an additional 100 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in Zeltiq Aesthetics by 2.1% in the third quarter. PNC Financial Services Group Inc. now owns 5,218 shares of the company’s stock valued at $205,000 after buying an additional 107 shares during the last quarter. Municipal Employees Retirement System of Michigan boosted its stake in Zeltiq Aesthetics by 1.2% in the third quarter. Municipal Employees Retirement System of Michigan now owns 9,910 shares of the company’s stock valued at $389,000 after buying an additional 120 shares during the last quarter. PineBridge Investments L.P. boosted its stake in Zeltiq Aesthetics by 4.9% in the second quarter. PineBridge Investments L.P. now owns 4,103 shares of the company’s stock valued at $112,000 after buying an additional 193 shares during the last quarter. Finally, New York State Teachers Retirement System boosted its stake in Zeltiq Aesthetics by 0.4% in the second quarter. New York State Teachers Retirement System now owns 47,852 shares of the company’s stock valued at $1,308,000 after buying an additional 200 shares during the last quarter.

ZLTQ has been the topic of a number of recent analyst reports. Canaccord Genuity lifted their target price on Zeltiq Aesthetics from $41.00 to $45.00 and gave the company a “buy” rating in a research report on Thursday. Zacks Investment Research upgraded Zeltiq Aesthetics from a “hold” rating to a “buy” rating and set a $41.00 target price on the stock in a research report on Wednesday, October 26th. Brean Capital reiterated a “buy” rating on shares of Zeltiq Aesthetics in a research report on Monday, October 24th. Stifel Nicolaus lifted their target price on Zeltiq Aesthetics from $38.00 to $52.00 and gave the company a “buy” rating in a research report on Wednesday, September 21st. Finally, Maxim Group lifted their target price on Zeltiq Aesthetics from $40.00 to $48.00 and gave the company a “buy” rating in a research report on Tuesday, August 9th. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $42.78.

Zeltiq Aesthetics Company Profile

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.

5 Day Chart for NASDAQ:ZLTQ

Receive News & Stock Ratings for Zeltiq Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc. and related stocks with our FREE daily email newsletter.